UC - ULCERATIVE COLITIS
Clinical trials for UC - ULCERATIVE COLITIS explained in plain language.
Never miss a new study
Get alerted when new UC - ULCERATIVE COLITIS trials appear
Sign up with your email to follow new studies for UC - ULCERATIVE COLITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for ulcerative colitis: drug combo trial launches
Disease control Recruiting nowThis study tests a new drug called OD-07656 in people with moderate to severe ulcerative colitis. The goal is to see if it is safe and can improve symptoms, and whether it can make a follow-up treatment (vedolizumab) work better. About 57 adults will take part in this early-stage…
Matched conditions: UC - ULCERATIVE COLITIS
Phase: PHASE2 • Sponsor: Odyssey Therapeutics • Aim: Disease control
Last updated May 01, 2026 15:58 UTC
-
Rethinking routine allergy shots for IBD patients on infliximab
Symptom relief Recruiting nowThis study looks at whether people with moderate-to-severe inflammatory bowel disease (IBD) need to routinely take dexamethasone (a steroid) before receiving infliximab to prevent allergic reactions. Researchers will compare those who get the pre-medication as usual with those wh…
Matched conditions: UC - ULCERATIVE COLITIS
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Symptom relief
Last updated May 17, 2026 04:16 UTC